FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Saturday

 

Distinguishing Among Forms of MS Will Lead to Better Treatment













































Dr. Jerry Wolinsky 
Image Source: BANDAGAINSTMS

Newswise — Understanding the boundaries between relapsing and progressive multiple sclerosis is essential to finding better therapeutic approaches and treatments for patients living with MS, according to Jerry S. Wolinsky, M.D., of the University of Texas in Houston. Wolinsky will deliver the first Kenneth P. Johnson Memorial Lecture at a forum hosted by Americas Committee for the Treatment and Research in Multiple Sclerosis (ACTRIMS), Feb. 18, 2016, in New Orleans.

“Recognition of the different forms of multiple sclerosis dates back to the earliest descriptions of the disease,” said Wolinsky. “By distinguishing between relapsing and progressive MS – in particular, the transition from early relapsing to secondary progressive MS – we hope to better understand and manage the progressive phase disease.”

Because there is no clear boundary, several researchers have suggested that the only way to understand progression in MS is to attempt to disentangle the contributions of relapses by carefully studying clinical attack free patients with “pure” primary progressive MS.

In his address, Wolinsky will focus on registration quality trials that illuminate possible answers and continued challenges for understanding and management of progressive phase disease, placed in context with experimental and translational data derived from smaller cohorts.

The late Kenneth P. Johnson, M.D., University of Maryland, led the effort to found ACTRIMS in 1996. The Memorial Lecture honors Johnson by providing an opportunity for ACTRIMS audiences to hear from prestigious clinicians or researchers selected for their knowledge, accomplishments and contributions related to MS. Wolinsky directs the MRI Analysis Center Multiple Sclerosis Research Group at the UT Health Science Center of Houston.

The lecture will be delivered on the opening day of ACTRIMS Forum 2016, Progressive MS: From Bench to Bedside and Back, Feb. 18 – 20, at the Hyatt Regency New Orleans. The forum is the first, standalone event ACTRIMS has held for North American researchers and clinicians who work in the rapidly changing field of MS.

To learn more about ACTRIMS Forum 2016, visit the event website, www.actrims.org/forum2016, and follow the event at #ACTRIMS2016.

About ACTRIMS
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) provides leadership in the field of multiple sclerosis and other demyelinating diseases. ACTRIMS® is a community of leaders dedicated to the treatment of and research in multiple sclerosis, dissemination of knowledge and education and collaboration among disciplines. Founded in 1995, it serves as the U.S. and Canadian counterpart to ECTRIMS, the European Committee on Treatment and Research in Multiple Sclerosis.

Contact:
Ann Nelson
608.310.8960
media@actrims.org
ACTRIMS
22 N. Carroll St., Suite 300
Madison, Wisconsin 53703 USA
Phone: +1 608 310 8960
Fax: + 1 608 251 4941

Related Experts

  • For Stories on @ConcussionMovie: Research by @UDelaware's Tom Buckley Shows Those with Concussion History Could Experience Impaired Walking
  • @NancyatHeart CEO @American_Heart on #obesity stats, #racial gaps from @CDCgov
  • Benjamin M. Segal, M.D., University of Michigan, Co-Chair of ACTRIMS Forum 2016
  • WashU Expert: Sepper calls for robust protections against discrimination in health care
  • Fiona Costello, MD, FRCPC, University of Calgary, is Co-Chair of ACTRIMS Forum 2016
  • Jack Antel, M.D., McGill University, President-Elect of ACTRIMS
  • SPRINT Trial Could Have Big Impact on How High Blood Pressure Is Treated
  • SPRINT clinical trial could change treatment for hypertension, impacting millions – experts available on impacts, #geriatrics, kidney disease #AHA15 #blood pressure

Story Source: The above story is based on materials provided by NEWSWISE
Note: Materials may be edited for content and length


Go to Newer News Go to Older News